🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

US LevFin Wrap — Medline looks to mega TLB repricing, Truist Insurance pushes tight LBO debt

Share

Market Wrap

US LevFin Wrap — Medline looks to mega TLB repricing, Truist Insurance pushes tight LBO debt

David Bell's avatar
Bill Weisbrod's avatar
  1. David Bell
  2. +Bill Weisbrod
  3. + 1 more
6 min read

If anyone needs to time a repricing deal perfectly, it’s the issuer of the biggest leveraged loan in the market. So let’s see how things play out for Medline, which launched an effort to reprice its massive $6.143bn TLB due 2028 via Bank of America on Thursday.

The healthcare products supplier is part of a new wave of loan repricings this week, after it initially appeared that the repricing boom of January and February had subsided. More than $9.3bn of loans were repriced this week, up from $7bn last week.

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks